Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from JD Health International, Inc. ( (HK:6618) ).
JD Health International, Inc. announced the successful approval of all proposed resolutions during its Extraordinary General Meeting held on December 8, 2025. The resolutions include agreements with JD.com for technology and traffic support services and the provision of healthcare products and services, which are expected to strengthen the company’s operational capabilities and market position.
The most recent analyst rating on (HK:6618) stock is a Buy with a HK$70.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International, Inc. operates in the healthcare industry, providing technology and traffic support services, as well as healthcare products and services. The company focuses on leveraging its technological capabilities to enhance healthcare delivery and access.
Average Trading Volume: 7,249,752
Technical Sentiment Signal: Buy
Current Market Cap: HK$193.2B
For a thorough assessment of 6618 stock, go to TipRanks’ Stock Analysis page.